Satellite Symposium at the
18th Meeting of the European Association for Haematopathology (EAHP)
CD30 testing: an important step towards precision medicine in haematological malignancies
3rd September 2016 18:30-19:30
Room San Francisco, Congress Center Basel
Basel, Switzerland

PLEASE CONFIRM:

I accept these terms:

 

 

 

 

 

 

 

 

 

 

Chairs:

Stefano Pileri
Italy

Randy Gascoyne
Canada
This website is an
Excerpta Medica activity.
logos
Organized and funded by
logos

*Takeda Oncology is the oncology business unit brand of Takeda Pharmaceutical Company Limited.
Takeda Oncology and its logo are trademarks of Takeda Pharmaceutical Company Limited.
Seattle Genetics and its logo are trademarks of Seattle Genetics, Inc.